SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Heightened geopolitical tensions in the Middle East, particularly concerning Iran and Israel, are sparking intense debate around SPY, as initial futures show a relatively muted reaction despite fears of broader conflict. The community is divided between those anticipating a major market crash and others expecting an aggressive 'buy the dip' rebound, fueled by observations of a historically resilient market and rising oil prices.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

INDO is seeing significant discussion as escalating Middle East tensions ignite a surge in oil prices, with the community anticipating a substantial short squeeze driven by concerns over global supply routes and recalling the stock's historic parabolic moves during similar past conflicts.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas (ONDS) is trending amidst rising geopolitical conflicts, fueling speculation about increased demand for its drone and counter-UAS technology from global defense sectors, while the community actively discusses the potential for a short squeeze and upcoming contract announcements.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid intense community debate surrounding recent military operations in Iran, with supporters hailing it as a decisive action against perceived threats while critics condemn it as an unlawful conflict and a costly distraction from other controversies. The discussion is heavily polarized, focusing on geopolitical ramifications, potential economic impacts, and the unfortunate American casualties.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp. is trending as escalating Middle East tensions lead to market expectations of surging oil prices and potential supply disruptions, driving community speculation for a strong short squeeze due to the stock's high short interest and recent debt reduction.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as the community hotly debates escalating Middle East tensions and threats to global oil supply routes, anticipating a significant price surge while also considering the counter-effect of Venezuela's potential oil market reentry.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending amid escalating geopolitical tensions following reports of Iran's Supreme Leader's death from US-Israeli strikes, which has intensified concerns about major oil supply disruptions in the Strait of Hormuz. The community is actively debating whether this will lead to a sustained parabolic rally in oil prices or a short-term "sell the news" reaction.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as escalating geopolitical tensions in the Middle East and concerns over potential oil supply disruptions fuel a sharply divided community sentiment, with some predicting a market crash while others anticipate a swift "buy the dip" rebound.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending amid escalating Middle East tensions, driving community discussion around increased defense spending and potential contract boosts for major players, which is further amplified by the company's strong financial outlook and record backlog.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending due to escalating Middle East tensions impacting global LNG shipping and an anticipated strong earnings report, with the community actively discussing potential price surges and the company's significant undervaluation given its expanding capacity and strategic market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Revance Therapeutics surged more than 16% on Monday morning, reaching over a month’s high, leading to a jump in retail chatter on Stocktwits.The surge followed a proposal from privately held Swiss medical aesthetics company Teoxane to acquire the anti-wrinkle injection maker for $3.60 per share in cash.&nbsp;The offer represents a 16% premium over the $3.10-per-share agreement with Crown Laboratories&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rvnc-stock-tanks-after-crown-labs-halves-takeover-price/cJabclHRig">announced</a> last month.Revance has yet to comment publicly on the proposal, but the news triggered a spike in message volume on Stocktwits, where retail sentiment remained cautious with a ‘neutral’ score.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/RVNC_sentiment_and_message_volume_Jan_6_1855360b7a.png" alt="RVNC sentiment and message volume Jan 6.png" width="1318" height="324"><figcaption>RVNC sentiment and message volume Jan 6 as of 10:45 am ET | source: Stocktwits</figcaption></figure>Last year, Crown agreed to purchase Revance for $6.66 per share, but the deal faced delays due to a dispute with Teoxane over Revance’s breach of a 2020 distribution agreement.&nbsp;The agreement had made Revance the exclusive commercialization partner for Teoxane’s dermal fillers. After resolving the dispute, Revance and Crown amended their deal, slashing the takeover price by more than half, reducing it to approximately $323 million.Teoxane currently holds 6.2% of Revance’s outstanding shares.&nbsp;Despite the uptick in shares following the Teoxane proposal, Revance's stock has struggled recently, plunging around 65% last year.Last year, Revance Therapeutics announced the commercial launch of DAXXIFY for injection for the treatment of cervical dystonia, marking its entry into the expanding U.S. therapeutics neurotoxin market, which could play a role in reshaping its future prospects.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Revance Therapeutics Stock’s Retail Sentiment Muted Even As Teoxane Makes Better Offer Than Crown Labs

The offer represents a 16% premium over the $3.10-per-share agreement with Crown Laboratories announced last month.

Equity

Shares of Revance Therapeutics Inc. plummeted over 20% to a four-month low Monday after private skincare firm Crown Laboratories drastically reduced its takeover offer.Crown will now acquire Revance in an all-cash deal valued at $3.10 per share, down from the initial August agreement of $6.66 per share.&nbsp;The revised deal, worth about $325 million in total equity, marks an 18.9% discount to Revance’s Dec. 6 closing price.&nbsp;The acquisition will make Revance a private company, with the deal expected to close in the first quarter of 2025.The price cut follows a notice received by Revance in September alleging violations of an exclusive distribution agreement with Teoxane.&nbsp;Both companies acknowledged that these violations could significantly impact Revance’s profitability and cash flows, prompting the adjustment.<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_09_at_11_31_10_AM_0b2b5cca48.png" alt="Screenshot 2024-12-09 at 11.31.10 AM.png" width="1314" height="320"><figcaption>RVNC sentiment and message volume on Dec. 9 as of 11:30 am ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned sharply bearish, accompanied by ‘extremely high’ message volume as investors expressed frustration.&nbsp;Posts highlighted disappointment with the slashed valuation and uncertainty about Revance’s future.<stembedurl>https://stocktwits.com/Hedgieguy75/message/595701639</stembedurl><stembedurl>https://stocktwits.com/jamstah/message/595671321</stembedurl>Revance, known for its anti-wrinkle injections, has faced a challenging year, with shares down 56.5% so far this year.For updates and corrections email newsroom[at]stocktwits[dot]com.

Revance Therapeutics Stock Plummets To 4-Month Low As Crown Labs Halves Takeover Offer: Retail Fumes

The price cut follows a notice received by Revance in September alleging violations of an exclusive distribution agreement with Teoxane.

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.

Revance Therapeutics Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

RVNC
Revance Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RVNC News

RVNCRevance Therapeutics Inc